Skip to main content
Table of Contents
Print

Can cannabis for sleep apnoea reduce CPAP dependence? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Continuous positive airway pressure (CPAP) is the standard treatment for obstructive sleep apnoea (OSA). This has led to interest in whether using cannabis to reduce CPAP dependence could offer a complementary approach. Patients and clinicians are exploring if cannabinoids might improve sleep quality and symptom management, potentially lessening reliance on CPAP devices. Understanding CPAP’s alternative, cannabis, is key for making informed treatment decisions. 

Exploring Cannabis as a Complement 

Before looking at potential benefits, it is important to note that using cannabis to reduce CPAP dependence remains experimental and should be approached with caution.  

Adjunctive support 

Cannabis may help improve sleep patterns and reduce discomfort related to CPAP use. Using cannabis to reduce CPAP dependence as a supportive measure may enhance adherence to existing therapy. 

Symptom relief 

For patients struggling with daytime fatigue or mild sleep disturbances, cannabinoids can provide targeted symptom management. CPAP’s replacement with cannabis is being studied but should not replace prescribed devices without medical guidance. 

Coordinated monitoring 

Healthcare providers stress careful monitoring when integrating cannabis with CPAP. Combining therapies responsibly ensures safety and maximises potential benefits without compromising treatment outcomes. 

In summary, using cannabis to reduce CPAP dependence may offer supportive advantages, but it should always be used thoughtfully alongside established OSA treatments. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories